Dassault Systèmes: new deal between Medidata and Bioforum
(CercleFinance.com) - Medidata, the life sciences subsidiary of Dassault Systèmes, announced Tuesday evening that it has sealed a new agreement with Bioforum, a research organisation dedicated to clinical trials.
This strengthened partnership, which follows more than a decade of collaboration, plans to offer Bioforum's biotech customers broader access to Medidata's AI-optimized clinical development technology.
In addition to the solutions already leveraged by Bioforum for 60 studies in various therapeutic areas, the CRO will now use Medidata's tools designed to streamline data flow, maintain data integrity and ensure compliance.
Specialising in biometric services and solutions for the pharmaceutical, biotech and medical device industries, Bioforum provides everything from data management and biostatistics to statistical programming and medical writing to help laboratories bring new drugs to market faster.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
This strengthened partnership, which follows more than a decade of collaboration, plans to offer Bioforum's biotech customers broader access to Medidata's AI-optimized clinical development technology.
In addition to the solutions already leveraged by Bioforum for 60 studies in various therapeutic areas, the CRO will now use Medidata's tools designed to streamline data flow, maintain data integrity and ensure compliance.
Specialising in biometric services and solutions for the pharmaceutical, biotech and medical device industries, Bioforum provides everything from data management and biostatistics to statistical programming and medical writing to help laboratories bring new drugs to market faster.
Copyright (c) 2024 CercleFinance.com. All rights reserved.